Katja Deterding News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Katja Deterding. Real-time updates on events, politics, business and more.

Real-world studies show efficacy, safety of BLV monotherapy in patients with HDV-related compensated cirrhosis

March 21, 2023

In 2020, bulevirtide (BLV) was conditionally approved for treating chronic hepatitis delta (CHD), an inflammation of the liver caused by hepatitis D virus (HDV).

Katja Deterding Pietro Lampertico Granda Ospedale Maggiore Policlinico Emily Henderson Division Of Gastroenterology Hannover Medical School

Source: news-medical.net

Equine hepatitis virus helps scientists understand hepatitis C in humans

March 2, 2022

The equine hepatitis virus could represent a powerful model to better understand hepatitis C infection in humans, say researchers.

Richardjp Brown Daniel Todt Thomas Pietschmann Jessikamv Cavalleri Eike Steinmann C Thomas Bock

Source: horsetalk.co.nz

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Katja Deterding News Today

Real-world studies show efficacy, safety of BLV monotherapy in patients with HDV-related compensated cirrhosis

Equine hepatitis virus helps scientists understand hepatitis C in humans

Explore More Categories